DN is clearly related to an activated renin–angiotensin system (RAS), whereby inhibition of the components of the system [e.g., ACE (angiotensin II generating enzyme) or AT1 (angiotensin II receptor type 1)] can reduce the disease severity20. This evidence concerns the gene REN and liver dysplastic nodule.